Actively Recruiting
Circulating microRNAs and Adverse Cardiovascular Outcomes in Patients With Coronary Artery Disease
Led by National Taiwan University Hospital · Updated on 2025-07-17
460
Participants Needed
1
Research Sites
409 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Coronary artery disease (CAD) resulting from atherosclerotic obstruction of epicardial coronary arteries accounts for more than one-third of deaths in subjects over the age of 35 worldwide. The global incidence of CAD is on the rise owing to the international epidemic of obesity, type 2 diabetes and aging, all of which are potent risk factors for coronary atherosclerosis. Participants with CAD are at high risk for subsequent adverse cardiovascular (CV) events and death; it has been estimated that one out of every five CAD patients will experience at least one adverse CV event during a 5-year follow up period. There is, however, no reliable diagnostic tool to predict the risk of adverse CV events or death in participanrs with CAD. Increasing evidence suggests that miRNAs are stably present in serum, plasma, urine, saliva and other body fluids and are considered a novel class of non-invasive biomarkers for various diseases including cancer, neurodegenerative and cardiovascular diseases
CONDITIONS
Official Title
Circulating microRNAs and Adverse Cardiovascular Outcomes in Patients With Coronary Artery Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female older than 20 years old
- History of cardiovascular disease, including coronary heart disease or peripheral vascular disease
You will not qualify if you...
- Significant valvular or congenital heart disease
- Cancer
- Receiving immunosuppressive therapy
- Other conditions or treatments deemed unsuitable by your physician
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NTUH
Taipei, Taiwan
Actively Recruiting
Research Team
C
Chau chung Wu, PhD
CONTACT
M
Mei chen Huang, Master
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here